ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

REGN Regeneron Pharmaceuticals Inc

1 039,11
0,00 (0,00%)
Avant marché
Dernière mise à jour : 13:29:59
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 63
Prix Achat 1 030,00
Prix Vente 1 046,00
Actualités -
Nom Action Symbole Action Marché Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 1 039,11 13:29:59
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1 039,11
Transactions Totales Volume échangé Volume en moyenne
23 63 -
Dernière Transaction Type Quantités échangées Prix transaction Devise
13:30:13 2 US$ 1 041,04 USD

Flux d'options Regeneron Pharmaceuticals (REGN)

Flux global

Haussier

Prime nette

195k

Calls / Puts

400,00%

Ach. / Vent.

25,00%

OTM / ITM

66,67%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
114,05B 109,76M - 13,12B 3,95B 36,02 28,85
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Regeneron Pharmaceuticals

Date Heure Source Titre
17/6/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/6/202412:10GlobeNewswire Inc.Updated Linvoseltamab Data Showcase Continued Deepening of..
14/6/202422:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
13/6/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/6/202413:00GlobeNewswire Inc.Kevzara® (sarilumab) Approved by FDA for the Treatment of..
10/6/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/6/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..

Forum Action Regeneron Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Regeneron Pharmaceuticals Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine0,000,000,000,0000,000,00%
1 mois0,000,000,000,0000,000,00%
3 mois0,000,000,000,0000,000,00%
6 mois0,000,000,000,0000,000,00%
1 an0,000,000,000,0000,000,00%
3 ans0,000,000,000,0000,000,00%
5 ans0,000,000,000,0000,000,00%

Dernières Valeurs Consultées

Delayed Upgrade Clock